Craniofaringioma

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51.Texto completo  Resumo

Karavitaki N, Cudlip S, Adams CB, et al. Craniopharyngiomas. Endocr Rev. 2006 Jun;27(4):371-97. Resumo

Gan HW, Morillon P, Albanese A, et al. National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol. 2023 Sep;11(9):694-706. Resumo

Hoffman LM, Jaimes C, Mankad K, et al. Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. Neuro Oncol. 2023 Feb 14;25(2):224-33.Texto completo  Resumo

1. Adamson TE, Wiestler OD, Kleihues P, et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990;73:12-17. Resumo

2. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51.Texto completo  Resumo

3. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002 Jul;97(1):3-11. Resumo

4. Carmel PW, Antunes JL, Chang CH. Craniopharyngiomas in children. Neurosurgery. 1982 Sep;11(3):382-9. Resumo

5. Karavitaki N, Cudlip S, Adams CB, et al. Craniopharyngiomas. Endocr Rev. 2006 Jun;27(4):371-97. Resumo

6. Baskin DS, Wilson CB. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg. 1986 Jul;65(1):22-7. Resumo

7. Defoort-Dhellemmes S, Moritz F, Bouacha I, et al. Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab. 2006 Apr;19(suppl 1):321-4. Resumo

8. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998 Oct;89(4):547-51. Resumo

9. Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005 Aug;21(8-9):640-8. Resumo

10. Hopper N, Albanese A, Ghirardello S, et al. The preoperative endocrine assessment of craniopharyngiomas. J Pediatr Endocrinol Metab. 2006 Apr;19(suppl 1):325-7. Resumo

11. Dhellemmes P, Vinchon M. Radical resection for craniopharyngiomas in children: surgical technique and clinical results. J Pediatr Endocrinol Metab. 2006 Apr;19(suppl 1):329-35. Resumo

12. Garre ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007 Aug;19(4):471-9. Resumo

13. Haupt R, Magnani C, Pavanello M, et al. Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab. 2006 Apr;19(suppl 1):289-93. Resumo

14. Price M, Ballard C, Benedetti J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors dDagnosed in the United States in 2017-2021. Neuro Oncol. 2024 Oct 6;26(supplement_6):vi1-85.Texto completo  Resumo

15. Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011 Sep;104(3):755-63. Resumo

16. Zacharia BE, Bruce SS, Goldstein H, et al. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol. 2012 Aug;14(8):1070-8. Resumo

17. Lithgow K, Pohl U, Karavitaki N. Craniopharyngiomas. In: Feingold KR, Anawalt B, Boyce A, et al, eds. Endotext [internet]. South Dartmouth, MA: MDText.com, Inc; 2000 (last updated 2019).Texto completo  Resumo

18. Crotty TB, Scheithauer BW, Young WF, et al. Papillary craniopharyngiomas: a clinicopathological study of 48 cases. J Neurosurg. 1995 Aug;83(2):206-14. Resumo

19. Hofmann B, Kreutzer J, Saeger W, et al. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Path. 2006 Dec;30(12):1595-603. Resumo

20. Larkin S, Karavitaki N. Recent advances in molecular pathology of craniopharyngioma. F1000Res. 2017 Jul 24;6:1202.Texto completo  Resumo

21. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007 Jan;106(1 suppl):3-12. Resumo

22. Rajan B, Ashley S, Thomas DG, et al. Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):517-21. Resumo

23. Hukin J, Visser J, Sargent M, et al. Childhood craniopharyngioma: Vancouver experience. Childs Nerv Syst. 2005 Aug;21(8-9):758-65. Resumo

24. Zada G, Lin N, Ojerholm E, et al. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010 Apr;28(4):E4. Resumo

25. Sorva R, Heiskanen O, Perheetupa J. Craniopharyngioma surgery in children: endocrine and visual outcome. Childs Nerv Syst. 1988 Apr;4(2):97-9. Resumo

26. Gan HW, Morillon P, Albanese A, et al. National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol. 2023 Sep;11(9):694-706. Resumo

27. Price DA, Jönsson P. Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database. Acta Paediatr Suppl. 1996 Oct;417:83-5. Resumo

28. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand. 1988 Jul;77(4):587-92. Resumo

29. Curran JG, O'Connor E. Imaging of craniopharyngioma. Childs Nerv Syst. 2005 Aug;21(8-9):635-9. Resumo

30. Hoffman LM, Jaimes C, Mankad K, et al. Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. Neuro Oncol. 2023 Feb 14;25(2):224-33.Texto completo  Resumo

31. Fischer EG, Welch K, Shillito J, et al. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg. 1990 Oct;73(4):534-40. Resumo

32. Clark AJ, Cage TA, Aranda D, et al. Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr. 2012 Oct;10(4):293-301. Resumo

33. Hankinson TC, Palmeri NO, Williams SA, et al. Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg. 2013;49(3):131-6. Resumo

34. Mortini P, Losa M, Pozzobon G, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011 May;114(5):1350-9. Resumo

35. Children’s Cancer and Leukaemia Group. ​Craniopharyngioma: Guidelines for the management of children and young people (CYP) aged up to 19 years. Oct 2021 [internet publication].Texto completo

36. Stripp DC, Maity A, Janss AJ, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):714-20. Resumo

37. Komotar RJ, Starke RM, Raper DM, et al. Endoscopic skull base surgery: a comprehensive comparison with open transcranial approaches. Br J Neurosurg. 2012 Oct;26(5):637-48. Resumo

38. Hoffman HJ, De Silva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992 Jan;76(1):47-52. Resumo

39. Fong RP, Babu CS, Schwartz TH. Endoscopic endonasal approach for craniopharyngiomas. J Neurosurg Sci. 2021 Apr;65(2):133-9. Resumo

40. Soldozy S, Yeghyayan M, Yağmurlu K, et al. Endoscopic endonasal surgery outcomes for pediatric craniopharyngioma: a systematic review. Neurosurg Focus. 2020 Jan 1;48(1):E6.Texto completo  Resumo

41. Palmisciano P, Young K, Ogasawara M, et al. Craniopharyngiomas invading the ventricular system: a systematic review. Anticancer Res. 2022 Sep;42(9):4189-97.Texto completo  Resumo

42. Cossu G, Jouanneau E, Cavallo LM, et al. Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Acta Neurochir (Wien). 2020 May;162(5):1159-77. Resumo

43. Tan TSE, Patel L, Gopal-Kothandapani JS, et al. The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres. Eur J Endocrinol. 2017 Mar;176(3):359-69. Resumo

44. Clark AJ, Cage TA, Aranda D, et al. A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst. 2013 Feb;29(2):231-8. Resumo

45. Weiss M, Sutton L, Marcial V, et al. The role of radiation therapy in the management of childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1313-21. Resumo

46. Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):255-63. Resumo

47. Varlotto JM, Flickinger JC, Kondziolka D, et al. External beam irradiation of craniopharyngioma: long-term analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):492-9. Resumo

48. Yang I, Sughrue ME, Rutkowski MJ, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus. 2010 Apr;28(4):E5.Texto completo  Resumo

49. Fouda MA, Karsten M, Staffa SJ, et al. Management strategies for recurrent pediatric craniopharyngioma: new recommendations. J Neurosurg Pediatr. 2021 May 1;27(5):548-55.Texto completo  Resumo

50. Hill TK, Baine MJ, Verma V, et al. Patterns of care in pediatric craniopharyngioma: outcomes following definitive radiotherapy. Anticancer Res. 2019 Feb;39(2):803-7. Resumo

51. Zhang C, Verma V, Lyden ER, et al. The role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol. 2018 Aug;41(8):807-12. Resumo

52. Harary PM, Rajaram S, Hori YS, et al. The spectrum of radiation therapy options for craniopharyngioma: a systematic review. J Neurooncol. 2025 Jun;173(2):275-88. Resumo

53. Jalali R, Ghosh S, Chatterjee A, et al. High-precision radiotherapy achieves excellent long-term control and preserves function in pediatric craniopharyngioma-Subset analysis of a randomized trial. Neuro Oncol. 2025 Sep 17;27(8):2147-57. Resumo

54. Niranjan A, Kano H, Mathieu D, et al. Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):64-71. Resumo

55. Chung WY, Pan DH, Shiau CY, et al. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg. 2000 Dec;93(suppl 3):47-56. Resumo

56. Scarzello G, Buzzaccarini MS, Perilongo G, et al. Acute and late morbidity after limited resection and focal radiation therapy in craniopharyngiomas. J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:399-405. Resumo

57. Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol. 2007 Jan;82(1):90-5. Resumo

58. Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011 Jul;96(7):1981-91. Resumo

59. Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol. 2004 Apr;46(4):220-9.Texto completo  Resumo

60. Kiehna EN, Mulhem RK, Li C, et al. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006 Nov 20;24(33):5283-90. Resumo

61. Müller HL, Gebhardt U, Teske C, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after three year follow-up. Eur J Endocrinol. 2011 Jul;165(1):17-24. Resumo

62. Winkfield KM, Tsai HK, Yao X, et al. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer. 2011 Jul 1;56(7):1120-6. Resumo

63. Liubinas SV, Munshey AS, Kaye AH. Management of recurrent craniopharyngioma. J Clin Neurosci. 2011 Apr;18(4):451-7. Resumo

64. Julow J, Backlund E-O, Lanyi F, et al. Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery. 2007 Aug;61(2):288-95. Resumo

65. Van den Berg JH, Blaauw G, Breeman WA, et al. Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg. 1992 Oct;77(4):545-50. Resumo

66. Pollack IF, Lunsford LD, Slamovits TI, et al. Stereotaxic intracavitary irradiation for cystic craniopharyngiomas. J Neurosurg. 1988 Feb;68(2):227-33. Resumo

67. Zhang S, Fang Y, Cai BW, et al. Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev. 2016 Jul 14;7:CD008890.Texto completo  Resumo

68. Sahakitrungruang T, Klomchan T, Supornsilchai V, et al. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr. 2011 Jun;170(6):763-9. Resumo

69. Lo AC, Howard AF, Nichol A, et al. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1011-8. Resumo

70. Müller HL. Childhood craniopharyngioma. Pituitary. 2013 Mar;16(1):56-67. Resumo

71. Erfurth EM. Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):19-26. Resumo

72. Agosti E, Zeppieri M, Antonietti S, et al. Advancing craniopharyngioma management: a systematic review of current targeted therapies and future perspectives. Int J Mol Sci. 2024 Jan 5;25(2):723.Texto completo  Resumo

73. Brastianos PK, Twohy E, Geyer S, et al. BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023 Jul 13;389(2):118-26.Texto completo  Resumo

74. Wu ZP, Wang YL, Wang LC, et al. Case report: successful use of BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma. World Neurosurg. 2023 Dec;180:e117-26.Texto completo  Resumo

75. Aylwin SJ, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary. 2016 Oct;19(5):544-6.Texto completo  Resumo

76. Joshi N, Mueller S, Kline C. Current clinical trials for craniopharyngiomas: what's on the horizon? J Neurooncol. 2025 Apr;172(2):281-8.Texto completo  Resumo

77. Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999 Feb;90(2):237-50. Resumo

78. Yamada S, Fukuhara N, Yamaguchi-Okada M, et al. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study. J Neurosurg Pediatr. 2018 Jun;21(6):549-62.Texto completo  Resumo

79. Dekkers OM, Biermasz NR, Smit JW, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol. 2006 Mar;154(3):483-9. Resumo

80. Gupta DK, Ojha BK, Sarkar C, et al. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci. 2006 May;13(4):438-42. Resumo

81. De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996 Jul;85(1):73-81. Resumo

82. Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg. 1999 Feb;90(2):251-7. Resumo

83. Duff JM, Meyer FB, Ilstrup DM, et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery. 2000 Feb;46(2):291-302. Resumo

84. Roth P, Pace A, Le Rhun E, et al. Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO clinical practice guidelines for prophylaxis, diagnosis, treatment and follow-up. Ann Oncol. 2021 Feb;32(2):171-82.Texto completo  Resumo

85. Pereira AM, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2005 Feb;62(2):197-204. Resumo